NICE guidance specifies that semaglutide must be prescribed alongside dietary modification as part of a specialist weight management service, not as a standalone treatment
Legacy Community Health is here to help
Bio/Physico-chemical Assay WB IF WB IF Biological Activity In Vitro GLP-1 plays a role in the control of fasting glucose
Using lower doses of semaglutide is cheaper for patients, results in fewer side-effects and helps ensure that stocks of the drug, which are still limited, go further. Tapering semaglutide 353 of the 2,246 patients (83% female, median age 49 years, median BMI 31.5, average body weight 92kg/14st 7lb) started to taper off semaglutide after they had reached their target weight
Does This Side Effect Spell Doom for the GLP-1s
It inhibits growth but does not sterilize